ORAMED PHARMACEUTICALS INC. (ORMP)

Form 4 sales, Form 144 notices and lockup dates

Sales chart range
Log in to watch ORMP
Latest sale
$611k
Jul 1 · No plan
Form 4 sales
21
On record
Form 144 notices
0
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleUnusual
    Aug 9 2021

    Sold 220,000 shares at $20.11 ($4.4M)

    Kidron Nadav, President and CEO

    Sold 25.3% of holdings ($17.5M position)648,573 shares leftFirst sale on recordFiling

  2. 2 Form 4 saleUnusual
    Sep 16 +38 days

    Sold 21,100 shares at $20.99 ($443k)

    Rakin Kevin, Director

    Sold 27% of holdings ($1.6M position)57,004 shares leftFirst sale on recordFiling

  3. 3 Form 4 saleUnusual
    Nov 1 +46 days

    Sold 3,000 shares at $25.60 ($77k)

    Mayer Arie, Director

    Sold 100% of holdings ($77k position)0 shares leftFirst sale on recordFiling

  4. 4 Form 4 salePlan not stated
    Mar 21 +140 days

    Sold 10,000 shares at $9.41 ($94k)

    Rakin Kevin, Director

    Sold 17.6% of holdings ($533k position)46,661 shares leftFiling

  5. 5 Form 4 salePlan not stated
    Jan 3 +288 days

    Sold 13,325 shares at $12.55 ($167k)

    Rabinowitz Michael, Chief Commercial Officer

    Sold 9.6% of holdings ($1.7M position)126,143 shares leftFirst sale on recordFiling

  6. 6 Form 4 saleUnusual
    Mar 14 +70 days

    Sold 100,000 shares at $2.01 ($201k)

    Kidron Miriam, Chief Scientific Officer

    Sold 33.1% of holdings ($606k position)201,666 shares leftFirst sale on recordFiling

  7. 7 Form 4 saleNo plan
    Jul 1 +1205 days

    Sold 73,360 shares at $4.51 ($331k)

    Gabay Avraham, Chief Financial Officer

    No 10b5-1 planSold 9.8% of holdings ($3.4M position)671,785 shares leftFirst sale on recordFiling

  8. 8 Form 4 saleNo plan
    Jul 1 same day

    Sold 137,000 shares at $4.46 ($611k)

    Hexter Joshua, COO & CBO

    No 10b5-1 planSold 11.8% of holdings ($5.2M position)1M shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales, notices and lockups (21)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for ORMP
Source
Jul 1, 2026Hexter JoshuaCOO & CBOForm 4 sale137,000$611k11.8%No planSEC
Jul 1, 2026Gabay AvrahamChief Financial OfficerForm 4 sale73,360$331k9.8%No planSEC
Mar 14, 2023Kidron MiriamChief Scientific OfficerForm 4 sale100,000$201k33.1%UnusualSEC
Jan 3, 2023Rabinowitz MichaelChief Commercial OfficerForm 4 sale13,325$167k9.6%Plan not statedSEC
Mar 21, 2022Rakin KevinDirectorForm 4 sale10,000$94k17.6%Plan not statedSEC
Nov 1, 2021Mayer ArieDirectorForm 4 sale3,000$77k100.0%UnusualSEC
Sep 16, 2021Rakin KevinDirectorForm 4 sale21,100$443k27.0%UnusualSEC
Aug 9, 2021Kidron NadavPresident and CEOForm 4 sale220,000$4.4M25.3%UnusualSEC
Jul 10, 2018Kidron NadavPresident and CEOForm 4 sale61$3650.0%Plan not statedSEC
Aug 2, 2017Kidron MiriamChief Scientific OfficerForm 4 sale89,636$762k54.4%UnusualSEC
Apr 19, 2017Kidron MiriamChief Scientific OfficerForm 4 sale52,814$334k37.1%UnusualSEC
Mar 10, 2016Jacob HaroldDirectorForm 4 sale8,500$55k34.1%UnusualSEC
Dec 30, 2015Kidron MiriamChief Technology OfficerForm 4 sale50,000$445k26.0%UnusualSEC
Dec 9, 2015Berelowitz MichaelDirectorForm 4 sale700$7k3.0%Plan not statedSEC
Dec 8, 2015Berelowitz MichaelDirectorForm 4 sale1,300$11k5.2%Plan not statedSEC
Sep 11, 2014Kidron MiriamChief Technology OfficerForm 4 sale31,699$267k23.6%Plan not statedSEC
Sep 4, 2014Kidron MiriamChief Technology OfficerForm 4 sale8,301$78k5.8%Plan not statedSEC
Apr 1, 2014Kidron MiriamChief Technology OfficerForm 4 sale137,300$1.7M100.0%UnusualSEC
Mar 31, 2014Berelowitz MichaelDirectorForm 4 sale9,434$99k100.0%UnusualSEC
Dec 30, 2013Jacob HaroldDirectorForm 4 sale834$13k100.0%UnusualSEC
Sep 27, 2011Bronfeld Zeev10% ownerForm 4 sale350,000$98k5.7%Plan not statedSEC